about
Chinese Herbs Interfering with Cancer Reprogramming MetabolismOncostatic-Cytoprotective Effect of Melatonin and Other Bioactive Molecules: A Common Target in Mitochondrial RespirationDefects in mitochondrial metabolism and cancerMitochondrial calcium uniporter activity is dispensable for MDA-MB-231 breast carcinoma cell survivalTumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication.Cytochrome c1 in ductal carcinoma in situ of breast associated with proliferation and comedo necrosis.Enriched environment inhibits mouse pancreatic cancer growth and down-regulates the expression of mitochondria-related genes in cancer cells.Mitochondrial DNA Polymerase POLG1 Disease Mutations and Germline Variants Promote Tumorigenic Properties.Amplification of the UQCRFS1 Gene in Gastric Cancers.Impaired mitochondrial metabolism and mammary carcinogenesisPrognostic significance of ubiquinol-cytochrome c reductase hinge protein expression in patients with clear cell renal cell carcinoma.CYC1 Predicts Poor Prognosis in Patients with Breast Cancer.The mitochondrial calcium uniporter regulates breast cancer progression via HIF-1α.Apparent polyploidization after gamma irradiation: pitfalls in the use of quantitative polymerase chain reaction (qPCR) for the estimation of mitochondrial and nuclear DNA gene copy numbers.Identification of ubiquinol cytochrome c reductase hinge (UQCRH) as a potential diagnostic biomarker for lung adenocarcinomaTargeting metabolic plasticity in breast cancer cells via mitochondrial complex I modulation.Mitochondrial DNA mutations and breast tumorigenesis.Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma.Migration of mitochondrial DNA in the nuclear genome of colorectal adenocarcinoma.The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma.Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review).Targeting mitochondrial function for the treatment of breast cancer.Reciprocal modulation of histone deacetylase inhibitors sodium butyrate and trichostatin A on the energy metabolism of breast cancer cells.Green fluorescent protein alters the transcriptional regulation of human mitochondrial genes after gamma irradiation.Pyruvate uptake is increased in highly invasive ovarian cancer cells under anoikis conditions for anaplerosis, mitochondrial function, and migration.Identification of key genes in Gram‑positive and Gram‑negative sepsis using stochastic perturbation.Epigenetic modification of miR-663 controls mitochondria-to-nucleus retrograde signaling and tumor progression.Roles of Neuroglobin Binding to Mitochondrial Complex III Subunit Cytochrome c1 in Oxygen-Glucose Deprivation-Induced Neurotoxicity in Primary Neurons.Mitochondrial UQCRB as a new molecular prognostic biomarker of human colorectal cancer.Metabolic phenotyping of CHO cells varying in cellular biomass accumulation and maintenance during fed-batch culture.Oxaloacetate induces apoptosis in HepG2 cells via inhibition of glycolysis.Reversing wrinkled skin and hair loss in mice by restoring mitochondrial function
P2860
Q26744552-011F3D72-B609-4CC6-B0AD-0D6821B5E253Q26766876-0AE8F20B-B4C1-45DA-9222-2E12A980937BQ27694117-F7AE7E88-CA7B-454C-9FEF-9F8509FCDEE9Q33573447-537ECE25-6525-42EE-A269-D359B64B0ECCQ33632616-5B282A1B-4264-4B4C-9DC6-5CF27C6CBEB7Q33873665-1B7FE05B-071E-4B85-A68B-E6EB6DDFFF56Q34980981-FC3BD903-F9D3-405A-A572-05A505D2BA92Q35807951-405136B2-59E9-4A08-8E66-20089E5740FCQ36083597-3D40C194-897C-423A-9FCD-17F10D369D9BQ36636779-63F6272E-127B-4DDB-8D06-70EEF400C570Q36879491-FFFD1EB2-92AF-4E5B-AF29-A8707F91A262Q36894172-726B01EB-22A1-4040-AF64-4BCA3A60F536Q36895350-FED4D0D3-5008-4C4A-A128-5F990C642F7FQ37007197-265A117C-B4EA-4E4B-AFA6-BF9C02AF411CQ37058136-CC661517-7874-4664-B02C-A6F3B1361D13Q37452112-A413502A-A423-4916-9826-EC07B95D8B7BQ37477802-939B7521-FA87-40B3-B488-E69C239F6B26Q37699265-BB63D483-4275-4411-A37F-05FDECE2A5FCQ37726356-F8805A70-1344-481B-ACB3-37EA3D332FEBQ37747422-AD51F468-C357-4531-9ADC-86BFD07FAD44Q38066202-DEFE7CAD-37AC-45FE-A5F6-138B4ED7C518Q38264534-C57DBB2F-1AC9-4554-BCDB-EAF27946451FQ38928346-40370807-6050-46A0-B978-7C46B13EF56FQ39182956-4CF21AB3-5E05-47E7-AE3E-B7D939779FBEQ39296886-4A8B4DA5-3570-420C-B287-658CDD5B54F8Q40132534-12887F93-6C96-4D19-B195-D7086FA10FDEQ46275669-7E8D765B-00A3-4CB0-8E21-2D2461371B00Q46718557-F30A128B-D2B6-4269-A743-E4771B418505Q47113627-508E55A3-460F-4C92-8372-A4C80742DAF7Q47401579-3980C335-FB1F-42D3-875A-FF0BB048E902Q52658483-13CFA7A1-A868-4325-BA23-E2E5E084B8A8Q56874978-AD12180E-9BC0-4F9C-A321-183A011A28F4
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Impaired OXPHOS complex III in breast cancer
@ast
Impaired OXPHOS complex III in breast cancer
@en
Impaired OXPHOS complex III in breast cancer
@nl
type
label
Impaired OXPHOS complex III in breast cancer
@ast
Impaired OXPHOS complex III in breast cancer
@en
Impaired OXPHOS complex III in breast cancer
@nl
prefLabel
Impaired OXPHOS complex III in breast cancer
@ast
Impaired OXPHOS complex III in breast cancer
@en
Impaired OXPHOS complex III in breast cancer
@nl
P2093
P2860
P1433
P1476
Impaired OXPHOS complex III in breast cancer
@en
P2093
Ayyasamy Vanniarajan
Keshav K Singh
Kjerstin M Owens
Mariola Kulawiec
Mohamad Mokhtar Desouki
P2860
P304
P356
10.1371/JOURNAL.PONE.0023846
P407
P577
2011-08-25T00:00:00Z